| 10815213 |
Bruton's tyrosine kinase inhibitors |
John Robert Springer, Balekudru Devadas, Danny James Garland, Margaret L. Grapperhaus, Seungil Han +9 more |
2020-10-27 |
$309,700,000 |
| 10807936 |
3,6-dichlorosalicylic acid compounds and related synthetic processes |
Terri Boehm, Mangesh Bore, Jeffery Carroll, G. Davis Harris, Jr., Matthew D. McReynolds +1 more |
2020-10-20 |
|
| 10745376 |
Processes for the preparation of heteroaryl carboxylic acids |
William H. Miller |
2020-08-18 |
|
| 10519092 |
3,6-dichlorosalicylic acid compounds and related synthetic processes |
Terri Boehm, Mangesh Bore, Jeffery Carroll, G. Davis Harris, Jr., Matthew D. McReynolds +1 more |
2019-12-31 |
|
| 10266513 |
Bruton's tyrosine kinase inhibitors |
John Robert Springer, Balekudru Devadas, Danny James Garland, Margaret L. Grapperhaus, Seungil Han +9 more |
2019-04-23 |
$877,937,000 |
| 10239857 |
Processes for the preparation of 2-thiophenecarbonyl chloride |
William H. Miller |
2019-03-26 |
|
| 9856201 |
3,6-dichlorosalicylic acid compounds and related synthetic processes |
Terri Boehm, Mangesh Bore, Jeffery Carroll, G. Davis Harris, Jr., Matthew D. McReynolds +1 more |
2018-01-02 |
$10,041,000 |
| 7829572 |
Pyrido[4,3-d]pyrimidin-4(3H)-one derivatives as calcium receptor antagonists |
Mary Theresa Didiuk, Kevin Liu, David A. Griffith, Angel Guzman-Perez, Feng C. Bi |
2010-11-09 |
$576,165,000 |
| 7176198 |
1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease |
David W. Piotrowski, Eric Jon Jacobsen, Brad Acker, Donn Wishka, Vincent Groppi |
2007-02-13 |
$114,373,000 |
| 7001900 |
Azabicyclic compounds for the treatment of disease |
Eric Jon Jacobsen, Jason K. Myers, Donn Wishka, Steven Reitz, David W. Piotrowski +2 more |
2006-02-21 |
$334,287,000 |
| 6951868 |
Azabicyclic-phenyl-fused-heterocyclic compounds for treatment of disease |
David W. Piotrowski, Eric Jon Jacobsen, Brad Acker, Vincent Groppi |
2005-10-04 |
$168,640,000 |
| 6919359 |
Azabicyclic-substituted-heteroaryl compounds for the treatment of disease |
David W. Piotrowski, Jason K. Myers, Bruce N. Rogers, Eric Jon Jacobsen, Alice L. Bodnar +2 more |
2005-07-19 |
$201,677,000 |
| 6911543 |
Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
David W. Piotrowski, Eric Jon Jacobsen, Brad Acker, Donn Wishka, Steven Reitz |
2005-06-28 |
$179,326,000 |
| 6894042 |
Azabicyclic compounds for the treatment of disease |
David W. Piotrowski, Eric Jon Jacobsen, Brad Acker |
2005-05-17 |
|
| 6869946 |
Substituted azabicyclic moieties for the treatment of disease |
Eric Jon Jacobsen, Jason K. Myers, David W. Piotrowski, Vincent Groppi |
2005-03-22 |
$274,842,000 |
| 6858613 |
Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease |
Bruce N. Rogers, David W. Piotrowski, Eric Jon Jacobsen, Brad Acker, Donn Wishka +1 more |
2005-02-22 |
$353,517,000 |
| 6852716 |
Substituted-aryl compounds for treatment of disease |
David W. Piotrowski, Eric Jon Jacobsen, Brad Acker, Jason K. Myers, Vincent Groppi |
2005-02-08 |
$111,158,000 |
| 6849620 |
N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease |
Eric Jon Jacobsen, David W. Piotrowski, Brad Acker, Donn Wishka, Jeffrey Corbett +2 more |
2005-02-01 |
$221,993,000 |
| 6828330 |
Quinuclidine-substituted hetero-bicyclic aromatic compounds for the treatment of disease |
Donn Wishka, David W. Piotrowski, Vincent Groppi |
2004-12-07 |
|
| 5965595 |
2-Imidazolinylamino heterocyclic compounds useful as alpha-2 adrenoceptor agonists |
Peter J. Maurer, Jeffrey Joseph Ares, William Seibel, Russell James Sheldon, Raymond Todd Henry |
1999-10-12 |
$71,930,000 |
| 5914342 |
2-imidazolinylamino heterocyclic compounds useful as alpha-2 adrenoceptor agonists |
Peter J. Maurer, Jeffrey Joseph Ares, William Seibel, Russell James Sheldon, Raymond Todd Henry |
1999-06-22 |
$87,434,000 |
| 5663189 |
2-imidazolinylamino heterocyclic compounds useful as alpha-2 adrenoceptor agonists |
Peter J. Maurer, Jeffrey Joseph Ares, William Seibel |
1997-09-02 |
$46,075,000 |
